Active substance
Factor ix
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| OCTANINE F 1000 I.U\10ML VIAL | 1000 IU | Powder and solvent for solution for injection · Parenteral use | 1 Vial | SAR 1213.85 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTANINE F 500 IU | 500 IU | Powder and solvent for solution for injection · Parenteral use | 1 Vial | SAR 610.25 | Biological · Prescription | OCTAPHARMA | Valid |
| OCTANINE F 250IU VIAL | 200 IU | Solution · Parenteral use | 1 Vial | SAR 321.20 | Biological · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| REPLENINE-VF 500IU+10ML STERILISED WATER | 50 IU | Powder for injection · Parenteral use | 1 Vial | SAR 684.70 | Biological · Prescription | BIO-PRODUCT LAB | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
HEMOPHILIA B, ACQUIRED HEMOPHILIA
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.